Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19 -: Evidence for a role as a potent basement membrane degrading enzyme

被引:119
作者
Stracke, JO [1 ]
Hutton, M
Stewart, M
Pendás, AM
Smith, B
López-Otin, C
Murphy, G
Knäuper, V
机构
[1] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain
[3] Celltech Ltd, Slough SL1 4EN, Berks, England
关键词
D O I
10.1074/jbc.275.20.14809
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently cloned MMP-19 a novel matrix metalloproteinase, which, due to unique structural features, was proposed to represent the first member of a new MMP subfamily (Pendas, A.M., Knauper, V., Puente, X. S., Llano, E., Mattei, M. G., Apte, S., Murphy, G., and Lopez-Otin, C. (1997) J. Biol. Chem. 272, 4281-4286). A recombinant COOH-terminal deletion mutant of MMP-19 (pro Delta(260-508)MMP-19), comprising the propeptide and the catalytic domain, was expressed in Escherichia coli, refolded, and purified. Interestingly, we found that pro Delta(260-508)MMP-19 has the tendency to autoactivate, whereby the Lys(97)-Tyr(98) peptide bond is hydrolyzed, resulting in free catalytic domain. Mutation of two residues (Glu(88), Pro and Pro(90) --> Val) within the propeptide latency motif did not prevent autoactivation but the autolysis rate was somewhat reduced. Analysis of the substrate specificity revealed that the catalytic domain of MMP-19 was able to hydrolyze the general MMP substrate Mca-Pro-Leu-Gly-Dpa-Ala-Arg-NH, and, with higher efficiency, the stromelysin substrate Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2. Kinetic analysis of the interactions of the catalytic domain of MMP-19 with the natural MMP inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), showed strong inhibition using TIMP-2, TIMP-3, and TIMP-4, while TIMP-1 was less efficient. We also demonstrated that synthetic hydroxamic acid-based compounds efficiently inhibited the enzyme. The catalytic domain of MMP-19 was able to hydrolyze the basement membrane components type TV collagen, laminin, and nidogen, as well as the large tenascin-C isoform, fibronectin, and type I gelatin in vitro, suggesting that MMP-19 is a potent proteinase capable of hydrolyzing a broad range of extracellular matrix components. Neither the catalytic domain nor the full-length MMP-19 was able to degrade triple-helical collagen. Finally, and in contrast to studies with other MMPs, MMP-19 catalytic domain was not able to activate any of the latent MMPs tested in vitro.
引用
收藏
页码:14809 / 14816
页数:8
相关论文
共 46 条
[31]   Matrix metalloproteinases [J].
Nagase, H ;
Woessner, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21491-21494
[32]   DIFFERENT DOMAIN INTERACTIONS ARE INVOLVED IN THE BINDING OF TISSUE INHIBITORS OF METALLOPROTEINASES TO STROMELYSIN-1 AND GELATINASE-A [J].
NGUYEN, Q ;
WILLENBROCK, F ;
COCKETT, MI ;
OSHEA, M ;
DOCHERTY, AJP ;
MURPHY, G .
BIOCHEMISTRY, 1994, 33 (08) :2089-2095
[33]  
PARK AJ, 1991, J BIOL CHEM, V266, P1584
[34]   Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution [J].
Pendas, AM ;
Knauper, V ;
Puente, XS ;
Llano, E ;
Mattei, MG ;
Apte, S ;
Murphy, G ;
LopezOtin, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) :4281-4286
[35]  
Quesada AR, 1997, CLIN EXP METASTAS, V15, P26
[36]   Mechanisms of connective tissue matrix destruction in periodontitis [J].
Reynolds, JJ ;
Meikle, MC .
PERIODONTOLOGY 2000, 1997, 14 :144-157
[37]   PROTEOLYTIC AND NONPROTEOLYTIC ACTIVATION OF HUMAN NEUTROPHIL PROGELATINASE-B [J].
SANG, QX ;
BIRKEDALHANSEN, H ;
VANWART, HE .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1251 (02) :99-108
[38]   Articular chondrocyte tenascin-C production and assembly into de novo extracellular matrix [J].
Savarese, JJ ;
Erickson, H ;
Scully, SP .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1996, 14 (02) :273-281
[39]   Matrix metalloproteinase MMP-19 (RASI 1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis [J].
Sedlacek, R ;
Mauch, S ;
Kolb, B ;
Schätzlein, C ;
Eibel, H ;
Peter, HH ;
Schmitt, J ;
Krawinkel, U .
IMMUNOBIOLOGY, 1998, 198 (04) :408-423
[40]   DIFFERENT SUSCEPTIBILITY OF SMALL AND LARGE HUMAN TENASCIN-C ISOFORMS TO DEGRADATION BY MATRIX METALLOPROTEINASES [J].
SIRI, A ;
KNAUPER, V ;
VEIRANA, N ;
CAOCCI, F ;
MURPHY, G ;
ZARDI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8650-8654